September 01, 2021

IBRI IN THE NEWS: How autoimmunity starts

When Decio Eizirik began treating patients with type 1 diabetes in the 1980s, he was pretty sure about what was behind the disease: an immune system gone haywire. People with...

August 20, 2021

IBRI RESEARCH PUBLISHED: From pancreatic ß-cell gene networks to novel therapies for type 1 diabetes

Abstract Completion of the Human Genome Project enabled a novel systems - and network-level understanding of biology, but this remains to be applied for understanding the pathogenesis of type...

August 18, 2021

IBRI RESEARCH PUBLISHED: The pancreatic ß cell response to secretory demands and adaption to stress

Abstract Pancreatic β cells dedicate much of their protein translation capacity to produce insulin to maintain glucose homeostasis. In response to increased secretory demand, β cells can compensate by...

July 29, 2021

Open House to Celebrate 1st Anniversary

You're Invited to an Open House! We look forward to celebrating the 1st anniversary of our new building with you. You'll have an opportunity to tour our research labs...

July 14, 2021

IBRI IN THE NEWS: Research round-up: autoimmune disease

Tissues' shared response to attack Type 1 diabetes, lupus, multiple sclerosis and rheumatoid arthritis can all be characterized as the immune system attacking a person’s own tissues. There are...

July 09, 2021

IBRI RESEARCH PUBLISHED: A functional genomic approach to identify reference genes for human pancreatic beta cell real-time quantitative RT-PCR analysis

Abstract Exposure of human pancreatic beta cells to pro-inflammatory cytokines or metabolic stressors is used to model events related to type 1 and type 2 diabetes, respectively. Quantitative real-time...

June 09, 2021

Insilico Medicine Collaborates with the Indiana Biosciences Research Institute

Insilico Medicine , a global leader in deep learning for drug discovery and development, is pleased to announce that it has entered into a research collaboration with the Indiana Biosciences...

June 07, 2021

IBRI IN THE NEWS: BioCrossroads Adds to Board

BioCrossroads has added Adrienne Brown and Alan Palkowitz to its board of directors. Brown serves as vice president of US Diabetes at Eli Lilly and Co. and oversees commercial efforts...

June 01, 2021

BioCrossroads adds Lilly, Indiana Biosciences Research Institute executives to Board of Directors

Indianapolis, Ind. – BioCrossroads announces that Adrienne Brown, vice president of US Diabetes at Eli Lilly and Company, and Alan Palkowitz, PhD, president and CEO of the Indiana Biosciences Research...

May 06, 2021

IBRI Receives Greenovation Award from Kimberly-Clark

In 2020, the IBRI diverted more than 370 pounds of waste from landfills, by participating in the RightCycle Program with Kimberly-Clark Professional. View the video here ....

 1 2 3 4 5  ... Last 
2020 Annual Report cover

The IBRI 2020 Annual Report is now available. The report theme, ‘Shaping the Future of Translational Science,’ reflects the IBRI’s commitment to turning scientific discovery into improved outcomes for patients.